F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher

Amifostine has a long history and today could potentially help prevent the development of approximately 40,000 cancer cases each year - the goal of F3 Platform Biologics. Amifostine has traditionally…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.